LRRK2 and Parkinson disease: We compared the differences between healthy controls (HC, n = 184) and the overall PD group, as well as among the different PD subgroups, including iPD (n = 381), GBA-PD (n = 76), LRRK2-PD (n = 142), and SNCA-PD (n = 18) at baseline.